down arrow

Makers Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE987A01010
  • NSEID:
  • BSEID: 506919
INR
134.00
0.00 (0.00%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 871

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Cipla
Sun Pharma.Inds.
Torrent Pharma
Jeevan Scienti.
Makers Labs.
Mankind Pharma
Sunil Healthcare
Biofil Chemicals
Godavari Drugs
Ind-Swift
Why is Makers Laboratories Ltd ?
1
Weak Long Term Fundamental Strength with a -58.99% CAGR growth in Operating Profits over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.90
  • The company has been able to generate a Return on Equity (avg) of 2.94% signifying low profitability per unit of shareholders funds
2
Stock is technically in a Mildly Bearish range
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Makers Labs. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Makers Labs.
6.18%
0.11
57.67%
SENSEX
0.45%
0.02
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-4.17%
EBIT Growth (5y)
-58.99%
EBIT to Interest (avg)
1.90
Debt to EBITDA (avg)
4.96
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.29
Tax Ratio
23.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.39%
ROCE (avg)
4.92%
ROE (avg)
2.94%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
11
Industry P/E
27
Price to Book Value
1.20
EV to EBIT
81.18
EV to EBITDA
14.89
EV to Capital Employed
1.17
EV to Sales
0.80
PEG Ratio
0.05
Dividend Yield
NA
ROCE (Latest)
0.23%
ROE (Latest)
8.81%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
PAT(HY)

Higher at Rs 8.41 cr

ROCE(HY)

Highest at 14.67 %

DEBTORS TURNOVER RATIO(HY)

Highest at 6.61 times

-3What is not working for the Company
PAT(Q)

At Rs -0.30 cr has Fallen at -120.7 %

Loading Valuation Snapshot...
Here's what is working for Makers Labs.
Debtors Turnover Ratio- Half Yearly
Highest at 6.61 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Makers Labs.
Profit After Tax (PAT) - Quarterly
At Rs -0.30 cr has Fallen at -120.7 %
over average PAT of the previous four quarters of Rs 1.45 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)